Why NovoCure Stock Soared 29% in November
Shares of NovoCure (NASDAQ: NVCR), which makes devices for treating cancerous solid tumors with electric fields, rocketed 28.7% last month, according to data from S&P Global Market Intelligence. For context, the S&P 500 returned 3.6% in November.
The healthcare stock has gained 166% this year through Dec. 3, versus the broader market's 25.7% return.
Image source: NovoCure.
Source Fool.com
